2m 2m 2m 2m 2m 2m 2m
JASPER THERAPEU (JSPR)
NASDAQ
$0.58-$0.02 (-3.34%)
Price as of Oct 02, 2026 6:25 PM EDT- $19.9MMarket Cap
- -75.29%1-Year Change
- BiotechnologyIndustry
JASPER THERAPEU (JSPR)
$0.58-$0.02 (-3.34%)
JSPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.60 | ||
Change | +$0.02 (+3.10%) | ||
Open | $0.59 | ||
High | $0.64 | ||
Low | $0.58 | ||
Previous Close | $0.58 | ||
Volume | 294,573 | ||
30-Day Average Volume | 380,513 | ||
1-Week Change | 2.15% | ||
1-Month Change | -14.28% | ||
1-Year Change | -75.29% | ||
3-Year Change | -91.46% | ||
5-Year Change | -99.36% | ||
Fundamentals | |||
Shares Outstanding | 33.3M | ||
Total Assets | $11.8M | ||
Market Cap | $19.9M | ||
Enterprise Value | $13.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$6.9M | ||
EBIT | $0.00 | ||
EBITDA | $21,000.00 | ||
Net Working Capital | $3.7M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | 618 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/04/2024 | ||
Earnings & Revenue